Vitalab Pharmacy Recalls Sterile Injectable Due to Sterility Concerns
Vitalab Pharmacy, Inc. is recalling a sterile injectable drug product because airflow patterns may not support aseptic production, raising sterility concerns.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score according to the rubric, particularly given the risk of sterility failure in an injectable product.
Plain-English summary
Vitalab Pharmacy, Inc. is recalling Methionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml, a sterile injectable drug product. The recall involves 3 vials with Lot # 03052018@54 and an expiration date of 06/03/2018. The product was distributed to patients throughout the United States.
The recall was initiated due to a lack of assurance of sterility. Upon review of recent third-party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.
Patients who received this product should contact their healthcare provider or Vitalab Pharmacy, Inc. for further instructions on how to proceed.
The recalled product
- Product
- Methionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml, Sterile injectable, Vitalab Pharmacy, Inc
- Manufacturer
- Vitalab Pharmacy, Inc
- Category
- Drug — Injectable
- Hazard
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 03052018@54
- Exp 06/03/2018
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 6 recalled by Vitalab Pharmacy, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Vitalab Pharmacy, Inc
See all →- HighVitalab Pharmacy Recalls Sterile Injectable Drugs Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Methylcobalamin Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Pharmacy Recalls Sterile Injectable Drugs Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Pharmacy Recalls Sterile Injectable Drug Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereVitalab Alprostadil Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2018-05-16
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereIsomeric Pharmacy Recalls Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2017-05-03
- SevereCompounded Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SeverePartell Specialty Pharmacy Recalls Methionine Injection Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SevereFDA Recalls Compounded Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereCompounded Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- HighCompounded Injectable Medication Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20